Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
“Anti N3 Pglu Amyloid Beta Peptide Antibodies And Uses Thereof”
Abstract: The present invention provides anti-N3pGlu Aß antibodies or antigen-binding fragment thereof. In addition the present invention provides the use of the anti-N3pGlu Aß antibodies or antigen-binding fragment thereof for the treatment of Alzheimers disease.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
31 December 2012
Publication Number
51/2014
Publication Type
INA
Invention Field
BIO-CHEMISTRY
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2019-10-15
Renewal Date
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center City of Indianapolis State of Indiana 46285 United States of America.
Inventors
1. Jirong LU
c/o Eli Lilly and Company P. O. Box 6288 Indianapolis Indiana 46206-6288 U.S.A.
2. Ying TANG
c/o Eli Lilly and Company P. O. Box 6288 Indianapolis Indiana 46206-6288 U.S.A.
3. Ronald Bradley DEMATTOS
c/o Eli Lilly and Company P. O. Box 6288 Indianapolis Indiana 46206-6288 U.S.A.
Specification
PLEASE SEE THE SPECIFICATION ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | Form-5.pdf | 2013-01-02 |
| 2 | Form-3.pdf | 2013-01-02 |
| 3 | Form-1.pdf | 2013-01-02 |
| 4 | 10907-CHENP-2012 FORM-18 07-01-2013.pdf | 2013-01-07 |
| 5 | 10907-CHENP-2012 CORRESPONDENCE OTHERS 07-01-2013.pdf | 2013-01-07 |
| 6 | 10907-CHENP-2012 CORRESPONDENCE OTHERS 23-01-2013.pdf | 2013-01-23 |
| 7 | 10907-CHENP-2012 ASSIGNMENT 23-01-2013.pdf | 2013-01-23 |
| 8 | 10907-CHENP-2012 POWER OF ATTORNEY 03-05-2013.pdf | 2013-05-03 |
| 9 | 10907-CHENP-2012 FORM-13 03-05-2013.pdf | 2013-05-03 |
| 10 | 10907-CHENP-2012 CORRESPONDENCE OTHERS 03-05-2013.pdf | 2013-05-03 |
| 11 | 10907-CHENP-2012 AMENDED CLAIMS 03-05-2013.pdf | 2013-05-03 |
| 12 | 10907-CHENP-2012 CORRESPONDENCE OTHERS 24-05-2013.pdf | 2013-05-24 |
| 13 | 10907-CHENP-2012 FORM-3 24-05-2013.pdf | 2013-05-24 |
| 14 | FORM 2.pdf | 2014-11-22 |
| 15 | ABSTRACT.pdf | 2014-11-22 |
| 16 | 10907CHENP2012 FORM-13 02-01-2015.pdf | 2015-01-02 |
| 17 | IP 22502 Form 13.pdf | 2015-03-12 |
| 18 | IP 22502 covering letter and Form 1.pdf | 2015-03-12 |
| 19 | 10907-CHENP-2012-FER.pdf | 2017-10-09 |
| 20 | 10907-CHENP-2012-OTHERS [05-04-2018(online)].pdf | 2018-04-05 |
| 21 | 10907-CHENP-2012-FORM-26 [05-04-2018(online)]_31.pdf | 2018-04-05 |
| 22 | 10907-CHENP-2012-FORM-26 [05-04-2018(online)].pdf | 2018-04-05 |
| 23 | 10907-CHENP-2012-FORM 3 [05-04-2018(online)]_32.pdf | 2018-04-05 |
| 24 | 10907-CHENP-2012-FORM 3 [05-04-2018(online)].pdf | 2018-04-05 |
| 25 | 10907-CHENP-2012-FER_SER_REPLY [05-04-2018(online)].pdf | 2018-04-05 |
| 26 | 10907-CHENP-2012-CLAIMS [05-04-2018(online)].pdf | 2018-04-05 |
| 27 | 10907-CHENP-2012-HearingNoticeLetter18-09-2019.pdf | 2019-09-18 |
| 28 | 10907-CHENP-2012-Written submissions and relevant documents (MANDATORY) [03-10-2019(online)].pdf | 2019-10-03 |
| 29 | Marked up Claims_Granted 322852_15-10-2019.pdf | 2019-10-15 |
| 30 | Description_Granted 322852_15-10-2019.pdf | 2019-10-15 |
| 31 | Claims_Granted 322852_15-10-2019.pdf | 2019-10-15 |
| 32 | Abstract_Granted 322852_15-10-2019.pdf | 2019-10-15 |
| 33 | 10907-CHENP-2012-PatentCertificate15-10-2019.pdf | 2019-10-15 |
| 34 | 10907-CHENP-2012-IntimationOfGrant15-10-2019.pdf | 2019-10-15 |
| 35 | 10907-CHENP-2012-RELEVANT DOCUMENTS [18-03-2020(online)].pdf | 2020-03-18 |
Search Strategy
| 1 | 10907chenp2012_06-10-2017.pdf |